An Australian study recently investigated the effects of cannabis use in adolescents and young adults with treatment-resistant anxiety. More specifically, they looked at the use of cannabidiol (CBD) as the primary form of treatment.
For a period of 12 weeks, participants aged 12 to 25 years took between 200 and 800 mg of CBD per day. What followed was that 42.5% of participants noticed a reduction in the severity of anxiety symptoms compared to their state before treatment.
To keep up with breaking news stories like this, download our free business news app.
Scientists Used Two Methods to Measure Anxiety Relief
Scientists have determined CBD’s effectiveness in relieving anxiety in two ways:
- Self-assessment scale (which shows 42.5% effectiveness in reducing symptoms).
- Standard Hamilton’s Anxiety Rating Scale (which showed a 50.7% reduction in symptoms).
It’s important to note that the study published in The Journal of Clinical Psychiatry only looked at 31 participants, so it’s a small research group. Importantly, however, all participants did not experience an improvement in symptoms using traditional anxiety treatments, including pharmacological drugs and cognitive behavioral therapies (CBT).
During the study, participants continued their therapy – finding that CBD may be most effective when combined with traditional treatments.
The study’s authors admit that this only gives preliminary results and that more research is needed to determine the effectiveness of CBD in treating anxiety. Still, based on previous research on CBD and anxiety, the results are consistent, and it’s safe to say that CBD can actually help people with severe forms of anxiety.
“Our pilot study found that cannabidiol not only helped reduce anxiety symptoms but was also well tolerated,” said Dr. Paul Amminger, author of the study, in a press release.” The most common side effects were mild sedation and mild fatigue, but this was when the doses were increased and usually disappeared after a few days.”
This is one of the most notable aspects of CBD. SSRIs (Selective Serotonin Reuptake Inhibitors) and other anxiolytics can lead to suicidal thoughts, irritability, and sleep problems.
Problems with Anxiety Research
Admittedly, some experts are somewhat skeptical about this research. First, the study authors described patients as “resistant to treatment,” while many of the patients are young and likely had not completed behavioral therapy before receiving CBD.
The study also did not indicate whether participants had ever received SSRI medications before, which would explain why study participants reported their anxiety levels as severe.
It’s also worth discussing the fact that all participants took between 200 and 800 mg of CBD per day. Anyone who has ever used CBD products knows that this is a high dose of CBD. Most manufacturers recommend a dose of around 30 mg per day, although the dose should be determined individually for each individual.
An Effective Anxiety Treatment, But Can People Afford It?
With that being said, most average consumers will not be consuming as much CBD on a daily basis. It’s not that the body might not be able to cope with such a large dose (this study found no side effects). Instead, this dosage will simply be too expensive for most cannabis consumers.
Just look at the large bottle of CBD oil from the Hemp Combine. Its price is very attractive – $50 for 4000 mg of CBD. But according to these studies, a 240ml bottle of 4000mg of CBD will only last for 5 days (with 800mg of CBD daily) or 20 days (with 200mg of CBD daily). So, if you take a dose of 200mg of CBD per day, the monthly cost of the treatment will be about $80, and with a dose of 800mg of CBD per day, it will be a little over $300 per month.
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in Fakty Konopne, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
The TopRanked.io Weekly Digest: What’s Hot in Affiliate Marketing [1xBet Affiliate Program]
Wanna discover one weird sports betting niche with plenty of low-hanging fruit just waiting for you to exploit? Then read...
Which Are the Most Important Fintech News from February 2024
Monite secured $6 million in a top-up financing round, bringing its total seed-stage funding to $16 million. The funds will...
Spanish Pharma Listed Companies Reduce Their Profits by 37% in 2023
Of the Spanish pharma listed companies, PharmaMar has suffered the most significant drop in profits due to generic drug competition...
How Much Does Europe Invest in Sustainability
Europe is moving rapidly towards a renewal of the regulatory framework for sustainability , with the obligation for almost 50,000...
The German Medical Cannabis Market Could Be Worth Three Billion
Currently, the German medical cannabis market serves a relatively small part of the population, with approximately 28,000 patients, or less...